Clinical analysis of Klebsiella pneumoniae infection in patients with liver cirrhosis in Beijing

Table 2 Comparison of the disease information, n (%)

Variable		Death group (n = 12)	Improved group (n = 60)	χ2	P value
Site of infection	Lung	2 (16.7)	11 (18.3)	1.806	0.771
	Urinary tract	0 (0)	4 (6.7)
	Blood	6 (50)	30 (50)
	Ascites	1 (8.3)	7 (11.7)
	Pleural fluid	3 (25)	8 (13.3)
Carbapenem-resistant	Yes	3 (25)	1 (1.7)	10.376	0.001b
Co-infection with other bacteria	Yes	5 (41.7)	5 (8.3)	9.290	0.002b
Co-infection with fungal infections	Yes	3 (25)	7 (11.7)	1.486	0.223
Co-infection with viral infection	Yes	0 (0)	2 (3.3)	0.411	0.521
Nosocomial infection	Yes	4 (33.3)	10 (16.7)	1.773	0.183
Liver failure	Yes	11 (91.7)	11 (18.3)	25.344	0.000b
Liver cirrhosis	None	0 (0)	2 (3.3)	4.393	0.494
	HBV	5 (41.7)	30 (50)
	HCV	1 (8.3)	5 (8.3)
	Alcoholic	5 (41.7)	11 (18.3)
	Autoimmune	0 (0)	7 (11.7)
	Unknown	1 (8.3)	5 (8.3)
Hepatocellular carcinoma	Yes	3 (25)	16 (26.7)	0.014	0.905
Hepatic encephalopathy	0	4 (33.3)	43 (71.7)	22.851	0.001b
	1	0 (0)	10 (16.7)
	2	5 (41.7)	5 (8.3)
	3	1 (0.08)	2 (0.03)
	4	2 (0.17)	0 (0)
Gastrointestinal hemorrhage	Yes	4 (33.3)	14 (23.3)	0.533	0.465

^bP < 0.01.

HBV: Hepatitis C virus; HCV: Hepatitis C virus.